| Financial Year |
March 31 2022 |
| Monetary Funds |
296,660,186.99 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
151,795,494.16 |
| Accounts Receivable |
126,880,150.30 |
| Advances to Suppliers |
30,260,078.61 |
| Other Receivables |
604,260,996.32 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
2,511,130.00 |
| Inventories |
2,809,179,100.69 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
24,556,430.56 |
| Total Current Assets |
4,090,378,125.78 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
174,791,819.43 |
| Investment Properties |
2,601,451,836.67 |
| Fixed Assetes |
1,378,286,522.49 |
| Under-construction Projects |
2,766,016.93 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
98,220,211.77 |
| R&D expenses |
-- |
| Goodwill |
30,754,940.60 |
| Long-Term Deferred and Prepaid Expenses |
55,394,063.50 |
| Deferred Income Tax Assets |
124,867,433.57 |
| Other Non-Current Assets |
15,005,538.73 |
| Sub-Total of Non-Current Assets |
4,500,738,383.69 |
| Total Assets |
8,591,116,509.47 |
| Short-Term Loans |
490,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
27,712,469.21 |
| Accounts Payable |
278,891,086.05 |
| Accounts Received In Advance |
34,123,656.27 |
| Employee Compensation Payable |
40,880,541.49 |
| Taxes Payable |
404,453,794.62 |
| Interest Payable |
600,417,512.76 |
| Dividend Payable |
-- |
| Other payables |
2,034,824,234.44 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,217,498,296.51 |
| Other Current Liabilities |
56,051,450.54 |
| Sub-Total of Current Liabilities |
5,801,786,115.96 |
| Long-term Loans |
305,942,496.16 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
2,171,838,730.60 |
| Deferred Income Tax Liabilities |
28,467,302.32 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
2,509,116,825.32 |
| Total Liabilities |
8,310,902,941.28 |
| Paid-In Capital(Or Share Stock) |
1,828,076,415.00 |
| Capital Surplus |
2,502,071,488.95 |
| Surplus Reserve |
239,164,928.67 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-4,523,369,691.90 |
| Minority Stockholder's Interest |
234,270,427.47 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
45,943,140.72 |
| Owner's Equity（Stockholder's Equity） |
280,213,568.19 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
8,591,116,509.47 |
